High-Dose Interleukin-2 Administration in the Oncology Medical-Surgical Setting – An Innovation to Impact Cost Efficiencies, Clinical Outcomes and the Ideal Patient Experience

Authors

Deidre L. Kutzler RN, Lehigh Valley HealthFollow
Megan L. Derr RN, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

5-2014

Comments

Copyright © Lehigh Valley Health Network

Published In/Presented At

Kutzler, D., & Derr, M. (2014, May 1-4). High-dose interleukin-2 administration in the oncology medical-surgical setting – an innovation to impact cost efficiencies, clinical Outcomes and the ideal patient experience. Poster presented at: The Oncology Nursing Society (ONS) 39th Annual Congress, Anaheim, CA.

Kutzler, D., & Derr, M, (2014, October 30). High-Dose Interleukin-2 Administration in the Oncology Medical-Surgical Setting – An Innovation to Impact Cost Efficiencies, Clinical Outcomes and the Ideal Patient Experience. Poster presented at: Research Day 2014, Lehigh Valley Health Network, Allentown, PA.

Disciplines

Analytical, Diagnostic and Therapeutic Techniques and Equipment | Medical Specialties | Medicine and Health Sciences | Nursing | Oncology | Therapeutics

Department(s)

Patient Care Services / Nursing

Document Type

Poster